Haleon EPS - Earnings per Share 2023-2024 | HLN
Haleon annual and quarterly earnings per share history from 2023 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Haleon EPS for the quarter ending September 30, 2024 was $0.00, a 100% decline year-over-year.
- Haleon EPS for the twelve months ending September 30, 2024 was $0.12, a 14.71% increase year-over-year.
- Haleon 2024 annual EPS was $0.4, a 42.7% increase from 2023.
- Haleon 2023 annual EPS was $0.28, a 1.06% decline from 2022.
- Haleon 2022 annual EPS was $0.28, a 0% decline from 2021.
| Haleon Annual EPS | |
|---|---|
| 2024 | $0.40 |
| 2023 | $0.28 |
| 2022 | $0.28 |
| 2021 | $0.00 |
| Haleon Quarterly EPS | |
|---|---|
| 2024-09-30 | $0.00 |
| 2024-06-30 | $0.00 |
| 2024-03-31 | $0.12 |
| 2023-09-30 | $0.00 |
| 2023-03-31 | $0.10 |
| 2022-12-31 | $0.00 |
| 2022-06-30 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $47.015B | $14.355B |
| Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.372B | 27.70 |
| Boston Scientific (BSX) | United States | $149.971B | 37.54 |
| Stryker (SYK) | United States | $142.469B | 29.79 |
| EssilorLuxottica (ESLOY) | France | $128.310B | 0.00 |
| Medtronic (MDT) | Ireland | $109.952B | 15.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.265B | 0.00 |
| ResMed (RMD) | United States | $36.786B | 27.63 |
| GE HealthCare Technologies (GEHC) | United States | $32.917B | 15.63 |
| Agilent Technologies (A) | United States | $32.815B | 21.39 |
| Terumo (TRUMY) | Japan | $26.606B | 34.56 |
| Koninklijke Philips (PHG) | Netherlands | $21.242B | 14.90 |
| Insulet (PODD) | United States | $21.238B | 83.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.915B | 11.51 |
| Baxter (BAX) | United States | $15.293B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.517B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.313B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $5.465B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.133B | 18.46 |
| Perrigo (PRGO) | Ireland | $3.618B | 9.17 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.366B | 15.33 |
| ICU Medical (ICUI) | United States | $3.165B | 23.34 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.916B | 13.18 |
| LeMaitre Vascular (LMAT) | United States | $1.846B | 41.26 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.335B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.144B | 11.62 |
| Neogen (NEOG) | United States | $1.083B | 13.86 |
| Green Thumb Industries (GTBIF) | United States | $1.059B | 23.81 |
| BioLife Solutions (BLFS) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.971B | 12.41 |
| InMode (INMD) | Israel | $0.843B | 8.50 |
| Kestra Medical Technologies (KMTS) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.643B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.545B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.512B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.282B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 78.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.93 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Quanterix (QTRX) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.240B | 10.90 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.236B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.15 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.76 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.25 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |